Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention (Review)

Author： Wang   Ma   Zheng  

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.1, Iss.2, 2013-01, pp. : 215-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exosomes Function in Pro- and Anti-Angiogenesis

By  

Current Angiogenesis, Vol. 2, Iss. 1, 2013-07 ,pp. : 54-59

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?

By  

Current Angiogenesis, Vol. 2, Iss. 2, 2013-09 ,pp. : 126-134

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-03 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-01 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 60-65

Bentham Science Publishers

Access to resources Recommend Favorite